未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics
Xu, Kailun; Yin, Xiaoyang; Chen, Hui; Huang, Yuhui; Zheng, Xi; Zhou, Biting; Cai, Xue; Gao, Huanhuan; Tian, Miaomiao; Hu, Sijun; Zheng, Shu; Yuan, Changzheng; Nie, Yongzhan; Guo, Tiannan; Shao, Yingkuan
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Surufatinib plus doublet (FOLFOX/FOLFIRI) or triplet (FOLFOXIRI) chemotherapy as second-line therapy in metastatic colorectal cancer (mCRC): First-stage results of a randomized, open-label phase II trial
Lin, R.; Li, H.; Chen, X.; Zheng, L.; Hong, Y.; Su, L.; Li, C.; Zheng, S.; Su, L.
分享
收藏FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients
Xu, Kailun; Yin, Xiaoyang; Zhou, Biting; Zheng, Xi; Wang, Hao; Chen, Jing; Cai, Xue; Gao, Huanhuan; Xu, Xiaoming; Wang, Liuhong; Shen, Li; Guo, Tiannan; Zheng, Shu; Li, Baosheng; Shao, Yingkuan; Wang, Jian
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏